Last week, three companies priced their IPOs to go public: TCR2 Therapeutics, Stealth BioTherapeutics and Avedro, under the tickers TCRR, MITO and AVDR, respectively. All three companies operate in the healthcare industry, marking the second week in a row that three healthcare companies have gone public. In total, the three companies will raise $223 million in new capital.
Levi Strauss, the historic U.S. blue jean maker, has filed to go public this year, filing under the ticker LEVI. It has been rumored the 165-year-old retailer would go public since the middle of 2018, resulting in one of the most anticipated IPOs in the retail space recently. Levi Strauss had $5.6 billion in revenue last fiscal year and says that it hopes to use proceeds from the stock sale to provide cash for general corporate and operating purposes. The company also says it will seek opportunistic acquisitions to grow its business and brand after going public. The company was previously publicly traded from 1971 to 1985.